The Effect of Exercise on Recent Onset Low Back Pain in the Emergency Department

March 21, 2019 updated by: Jordan Miller, PT, PhD, Queen's University

Determining the Effects of Adding Exercise to Usual Care for Recent Onset Low Back Pain in the Emergency Department: A Randomized Controlled Trial

Low back pain (LBP) is the leading contributor to years lived with disability and an important contributor to healthcare costs and time off work. Exercise is effective for chronic low back pain, but there is a lack of evidence to inform whether exercise in the emergency department is effective for people with acute low back pain. This randomized controlled trial will evaluate the effectiveness of a brief exercise intervention provided in the emergency department for people with recent onset low back pain. People with acute low back pain (<1 week) will be randomly assigned to either usual care or to usual care plus a brief exercise intervention delivered by trained physiotherapy students. The study will evaluate the impact of the added exercises on self-reported disability (primary outcome), pain intensity, global rating of change, patient satisfaction, and adverse events. In addition, we will pilot data collection related to return to work, healthcare utilization, and cost effectiveness outcomes to determine the feasibility of conducting a future trial with additional patient participants required to evaluate these outcomes. Outcomes will be evaluated at baseline, 48-72 hours, 1-week, 1-month, and 3-months from their initial emergency department visit. The results of this study have the potential to inform emergency department management of acute low back pain.

Study Overview

Detailed Description

Low back pain (LBP) is the leading contributor to years lived with disability and an important contributor to healthcare costs and time off work. Exercise is effective for chronic low back pain, but there is a lack of evidence to inform whether exercise in the emergency department is effective for people with acute (<1 week) low back pain.

The objectives of this randomized controlled trial are:

  1. To determine the effectiveness of an exercise intervention delivered in the ED in comparison to usual ED care on pain, function, global rating of change, patient satisfaction, and adverse effects in adults with recent onset LBP (< 1 week).
  2. To determine the feasibility of a future RCT to evaluate the effects of the ED exercise intervention on return to work outcomes, health care utilization, and cost-effectiveness in comparison to usual care.

The investigators hypothesize that an exercise intervention in the ED will improve pain, function, global rating of change, and patient satisfaction in comparison to usual ED care with no difference in adverse effects.

Design: A randomized controlled trial (RCT) with two parallel arms (exercise and usual care).

Blinding: The patient will be partially blinded by our not providing full details on the two exercise approaches being studied. The health care providers delivering the interventions will not be blinded due to the nature of the intervention. However, research assistants administering the outcome measures will be blinded. The outcomes assessed are objective measures assessed using an online survey tool that will be free of assessor bias.

Randomization and allocation concealment: Participants will be randomized in a 1:1 ratio to exercise or usual care groups by an independent statistician using a computerized random number generator. The random allocation will be placed in sequentially numbered opaque envelopes. The envelopes will be opened by the RA after completion of baseline assessment.

Patient enrollment: Consecutive patients with acute LBP who are seeking urgent care at Kingston General Hospital Emergency Department (ED) and Hotel Dieu Hospital Urgent Care Clinic (UCC) will be invited to participate over a 4-month period May 1 through August 31, 2018). ED based research staff will screen patients for willingness to be invited to participate when they arrive at the ED. These staff will then invite participation once the physician assessment is complete and eligibility criteria are reviewed.

Inclusion criteria: English speaking adults (18-65 years) with recent onset LBP (<1 week).

Exclusion criteria: people with subacute/chronic LBP, previous episode of back pain in the past 3 months, fracture, previous back surgery, red flags (e.g. urinary retention, bilateral or multilevel neurological impairment), traumatic mechanism of injury (fall >3m or 3 steps, MVC >100km/h).

Assessment and outcome measures: All measures will be collected using Qualtrics, a secure online database, at baseline, 48-72 hours, 1-week, 1-month, and 3-months.

Baseline factors used to describe the population: age, gender, duration of back pain (hours), whether there have been previous episodes of back pain, whether or not the participant has pain in other areas of the body, medications, comorbidities, work status prior to onset of back pain, and current work status.

Objective #1: Individual health outcomes will be collected using validated tools described under the outcomes assessed.

Objective #2: This study design will not have adequate power or long-term follow-ups required to adequately evaluate return to work, healthcare use, and cost-effectiveness. The investigators plan to pilot the use of these outcomes to determine the feasibility of conducting a future trial to evaluate these outcomes.

Analysis: For objective #1, Repeated-measure linear mixed models will be used to assess the effect of treatment (exercise versus usual care) on our primary (disability) and secondary (pain, global rating of change, patient satisfaction, adverse effects) outcomes at all time-points (48-72 hours, 1-week, 1- and 3-months). A difference of 2 on the NPRS36 and 3 points on the RMDQ37 will be considered clinically meaningful. For objective #2, all feasibility outcomes will be reported descriptively and analyzed qualitatively as recommended by methods and reporting guidelines for pilot and feasibility studies.

Sample size: The investigators searched one year of ED and UCC records to identify LBP patients eligible for this study. 2000 patients/year attended for back pain with > 500 during our four-month recruitment period. Of these, a chart review suggests 43% of these met our eligibility criteria. Based on past trials in these settings, we expect at least 50% will consent resulting in a sample size of 107+. This will achieve over 90% power to detect a minimally important difference of 3 points on the RMQ, using a two-sided α=0.05 and assuming a standard deviation of 6.2 points and accounting for a 10% loss to follow-up. This will also provide an adequate sample to assess the secondary feasibility objectives.

Study Type

Interventional

Enrollment (Actual)

69

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Kingston, Ontario, Canada, K7L 3N6
        • Kingston Health Sciences Center - Kingston General Hospital and Hotel Dieu Hospital Sites

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • English speaking
  • Adults (18-65 years)
  • Recent onset low back pain (<1 week)

Exclusion Criteria:

  • Subacute/chronic LBP (> 1week)
  • Previous episode of low back pain in past 3 months
  • fracture
  • previous back surgery
  • urinary retention
  • saddle anaesthesia
  • bilateral or multilevel neurological impairment
  • traumatic mechanism of injury (fall >3m or 3 steps, MVC >100km/h).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise
Participants in the exercise intervention arm will receive the usual care protocol plus a standardized, evidence informed exercise intervention provided by trained physiotherapy students. The exercise intervention will begin with a brief assessment to rule out contraindications to exercise and to identify any directional preferences (e.g. pain with lumbar flexion and relief with extension). The PT will then be taught four standardized exercises: the pelvic tilt exercise, a rotational exercise, a tailored graded walking program taking into account the current abilities of the patient, and an exercise based on the directional preference of the individual. These will be re-enforced with a handout including the rationale, instructions and dosage recommendations for the exercises.
A standardized exercise program tailored to the individual based on their directional preferences and current functional abilities.
Participants will be advised that staying physically active and continuing to participate in usual activities improves recovery. This verbal advice will be reinforced with a written handout.
Participants will be advised on the appropriate use of ice or heat to manage pain. This verbal advice will be reinforced with a written handout.
Participants will receive education regarding the use of non-steroidal anti-inflammatory medications (NSAIDs) for pain relief, if needed and if the patient is appropriate for NSAIDs. Information regarding specific recommended doses, potential benefit and risk will be discussed.
Active Comparator: Usual care
Our usual care protocol was developed based on 30 responses to an 18 item survey of Queen's Department of Emergency Medicine physicians. Three themes emerged as interventions most commonly used. Each of these strategies has evidence for small, but positive treatment effects and low risk of harms: 1) advice to stay active and engaged in usual activities, 2) use of ice or heat to manage pain, and 3) recommendation for analgesia using NSAIDs if needed and appropriate.
Participants will be advised that staying physically active and continuing to participate in usual activities improves recovery. This verbal advice will be reinforced with a written handout.
Participants will be advised on the appropriate use of ice or heat to manage pain. This verbal advice will be reinforced with a written handout.
Participants will receive education regarding the use of non-steroidal anti-inflammatory medications (NSAIDs) for pain relief, if needed and if the patient is appropriate for NSAIDs. Information regarding specific recommended doses, potential benefit and risk will be discussed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported disability
Time Frame: Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
Roland Morris Questionnaire (0-24, higher represents greater disability)
Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Intensity currently
Time Frame: Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
Numeric pain rating scale (0-10, higher represents greater pain intensity)
Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
Pain intensity on average over past 24-hours
Time Frame: Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
Numeric pain rating scale (0-10, higher represents greater pain intensity)
Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
Pain intensity at its worst over the past 24-hours
Time Frame: Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
Numeric pain rating scale (0-10, higher represents greater pain intensity)
Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
Pain intensity at its least over the past 24-hours
Time Frame: Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
Numeric pain rating scale (0-10, higher represents greater pain intensity)
Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary comparison at 1-week
Global rating of change
Time Frame: 1-week, 1-month, 3-months with a primary comparison at 1-week
Perceived change in function (-5 to +5, higher represents greater improvement in function)
1-week, 1-month, 3-months with a primary comparison at 1-week
Patient satisfaction
Time Frame: 1-week, 1-month, 3-months with a primary comparison at 1-week
Satisfaction with healthcare received (-5 to +5, higher represents greater satisfaction with care)
1-week, 1-month, 3-months with a primary comparison at 1-week
Adverse effects
Time Frame: 1-week, 1-month, 3-months with a primary comparison at 1-week
Self-reported adverse effects of treatment
1-week, 1-month, 3-months with a primary comparison at 1-week
Treatment fidelity
Time Frame: At initial visit
A fidelity checklist performed by the physiotherapy students carrying out the intervention will be included as a process outcome.
At initial visit
Recruitment rate (to determine feasibility for future trial on healthcare utilization, cost-effectiveness and return to work)
Time Frame: Recruitment rate over 4 month period
Rate of recruitment (number of participants/week over recruitment period)
Recruitment rate over 4 month period
Retention rate (to determine feasibility for future trial)
Time Frame: Baseline, 1-week, 1-month, 3-months with a primary time-point of 3-month follow-up
Rate of assessment completion
Baseline, 1-week, 1-month, 3-months with a primary time-point of 3-month follow-up
Work status - working or not working (piloted to determine the feasibility of conducting a future trial evaluating return to work outcomes)
Time Frame: Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
Work status (working/not working)
Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
Work status - full or part time (piloted to determine the feasibility of conducting a future trial evaluating return to work outcomes)
Time Frame: Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
Work status (full/part-time)
Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
Work status - full or modified duties/hours(piloted to determine the feasibility of conducting a future trial evaluating return to work outcomes)
Time Frame: Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
Work status - full/modified duties or hours
Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
Work status - hours worked (piloted to determine the feasibility of conducting a future trial evaluating return to work outcomes)
Time Frame: Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
Number of hours worked in past seven days.
Baseline, 1-week, 1-month, 3-months with a primary time-point of 1-week
Healthcare utilization (piloted to determine the feasibility of conducting a future trial evaluating healthcare utilization)
Time Frame: 1-week, 1-month, 3-months with a primary time-point of 3-months
Self-report questoinnaire asking patient to report primary care visits, emergency room visits, hospitalizations, surgeries, consultations with other health care providers (e.g. physiotherapists, chiropractors, physician specialists, diagnostic imaging (e.g. x-ray, CT scan, MRI), and medication
1-week, 1-month, 3-months with a primary time-point of 3-months
Costs (piloted to determine the feasibility of conducting a cost-effectiveness analysis in a future trial)
Time Frame: All costs incurred between baseline and 3-month follow-up will be calculated
Includes all healthcare costs as well as societal costs using a human capital approach
All costs incurred between baseline and 3-month follow-up will be calculated
Quality of life (piloted to determine feasibility of performing cost-effectiveness analysis in a future trial)
Time Frame: Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary time-point of 3-months
EuroQOL 5D-5L (0-100 with greater score indicating greater quality of life)
Change from baseline to 3-months with repeated measures at baseline, 1-week, 1-month, 3-months and a primary time-point of 3-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jordan Miller, PhD, Queen's University
  • Principal Investigator: Robert Brison, MD, Kingston Health Sciences Center and Queen's University
  • Principal Investigator: Elizabeth Blackmore, MD, Kingston Health Sciences Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Actual)

November 30, 2018

Study Completion (Actual)

November 30, 2018

Study Registration Dates

First Submitted

April 19, 2018

First Submitted That Met QC Criteria

November 27, 2018

First Posted (Actual)

November 28, 2018

Study Record Updates

Last Update Posted (Actual)

March 25, 2019

Last Update Submitted That Met QC Criteria

March 21, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Exercise

Subscribe